- Home
- PALO vs INGN Comparison
PALO vs INGN Comparison
Compare PALO & INGN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | PALO | INGN |
|---|---|---|
| Founded | N/A | 2001 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Blank Checks | Industrial Specialties |
| Sector | Finance | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 211.0M | 177.1M |
| IPO Year | 2026 | 2013 |
Fundamental Metrics
Financial Performance| Metric | PALO | INGN |
|---|---|---|
| Price | $9.95 | $6.18 |
| Analyst Decision | | Strong Buy |
| Analyst Count | 0 | 4 |
| Target Price | N/A | ★ $11.25 |
| AVG Volume (30 Days) | 18.1K | ★ 179.0K |
| Earning Date | N/A | 05-07-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | ★ 43.42 |
| EPS | ★ N/A | N/A |
| Revenue | N/A | ★ $348,668,000.00 |
| Revenue This Year | N/A | $8.03 |
| Revenue Next Year | N/A | $7.76 |
| P/E Ratio | N/A | ★ N/A |
| Revenue Growth | N/A | ★ 3.86 |
| 52 Week Low | $9.89 | $5.34 |
| 52 Week High | $9.95 | $9.13 |
Technical Indicators
Market Signals| Indicator | PALO | INGN |
|---|---|---|
| Relative Strength Index (RSI) | 61.50 | 42.18 |
| Support Level | $9.90 | $6.00 |
| Resistance Level | N/A | $6.73 |
| Average True Range (ATR) | 0.02 | 0.23 |
| MACD | 0.00 | -0.02 |
| Stochastic Oscillator | 100.00 | 14.91 |
Price Performance
Historical ComparisonAbout PALO Paloma Acquisition Corp I Class A Ordinary Shares
Paloma Acquisition Corp I is a blank check company incorporated as a Cayman Islands exempted company and formed for the purpose of effecting a merger, amalgamation, share exchange, asset acquisition, share purchase, reorganization or similar business combination with one or more businesses or entities.
About INGN Inogen Inc
Inogen Inc is a medical technology business that focuses on respiratory health. It develops, manufactures, and markets respiratory health products, including portable oxygen concentrators, or POCs, used to deliver supplemental long-term oxygen therapy to patients suffering from chronic respiratory conditions and the Simeox product for airway clearance treatment. In addition, it has started distributing the Inogen Voxi 5 stationary oxygen concentrator as well as the Aurora continuous positive airway pressure, or CPAP, masks in the United States. The company derives revenues from customers through the development, manufacturing, marketing, sales, and rental of respiratory products.